{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:40:30Z","timestamp":1792273230641,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["ED12162"],"award-info":[{"award-number":["ED12162"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MFAG11542"],"award-info":[{"award-number":["MFAG11542"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG15191"],"award-info":[{"award-number":["IG15191"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004631","name":"Fondazione Antonio Carlo Monzino","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/501100004631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1060-z","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:03:23Z","timestamp":1549281803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKC\u03b5 and ZEB1 inhibition"],"prefix":"10.1186","volume":"38","author":[{"given":"Rihan","family":"El Bezawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Tinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Tortoreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Doldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zuco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Folini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Stucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Rancati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Valdagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gandellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"1060_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG guidelines on prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618\u201329.","journal-title":"Eur Urol"},{"key":"1060_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semradonc.2016.08.007","volume":"27","author":"A Tetreault-Laflamme","year":"2017","unstructured":"Tetreault-Laflamme A, Crook J. Options for salvage of radiation failures for prostate Cancer. Semin Radiat Oncol. 2017;27:67\u201378.","journal-title":"Semin Radiat Oncol"},{"key":"1060_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10555-014-9493-5","volume":"33","author":"L Chang","year":"2014","unstructured":"Chang L, Graham PH, Hao J, Bucci J, Cozzi PJ, Kearsley JH, et al. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy. Cancer Metastasis Rev. 2014;33:469\u201396.","journal-title":"Cancer Metastasis Rev"},{"key":"1060_CR4","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1038\/ncomms6671","volume":"5","author":"P Zhang","year":"2014","unstructured":"Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb BG, Chen D, et al. MiR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun. 2014;5:5671.","journal-title":"Nat Commun"},{"key":"1060_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-017-0624-9","volume":"16","author":"P Zhou","year":"2017","unstructured":"Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu Y, et al. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer. 2017;16:52.","journal-title":"Mol Cancer"},{"key":"1060_CR6","doi-asserted-by":"crossref","unstructured":"Yadav S, Kowolik CM, Lin M, Zuro D, Hui SK, Riggs AD, et al. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties. Mol Carcinog. 2018.","DOI":"10.1002\/mc.22913"},{"issue":"16","key":"1060_CR7","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/pros.23435","volume":"77","author":"TW Stark","year":"2017","unstructured":"Stark TW, Hensley PJ, Spear A, Pu H, Strup SS, Kyprianou N. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance. Prostate. 2017;77(16):1583\u201391.","journal-title":"Prostate"},{"key":"1060_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.yexcr.2017.11.037","volume":"362","author":"Y Jin","year":"2018","unstructured":"Jin Y, Xu K, Chen Q, Wang B, Pan J, Huang S, et al. Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K\/AKT pathway. Exp Cell Res. 2018;362:362\u20139.","journal-title":"Exp Cell Res"},{"key":"1060_CR9","doi-asserted-by":"publisher","first-page":"58595","DOI":"10.18632\/oncotarget.11193","volume":"7","author":"N Muhammad","year":"2016","unstructured":"Muhammad N, Bhattacharya S, Steele R, Ray RB. Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Oncotarget. 2016;7:58595\u2013605.","journal-title":"Oncotarget"},{"key":"1060_CR10","doi-asserted-by":"crossref","unstructured":"Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012:271\u201382.","DOI":"10.1038\/nrg3162"},{"key":"1060_CR11","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.7150\/thno.19934","volume":"7","author":"J Ni","year":"2017","unstructured":"Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y. Targeting microRNAs in prostate cancer radiotherapy. Theranostics. 2017;7:3243\u201359.","journal-title":"Theranostics"},{"key":"1060_CR12","doi-asserted-by":"crossref","first-page":"22439","DOI":"10.18632\/oncotarget.4210","volume":"6","author":"X Huang","year":"2015","unstructured":"Huang X, Taeb S, Jahangiri S, Korpela E, Cadonic I, Yu N, et al. miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD). Oncotarget. 2015;6:22439\u201351.","journal-title":"Oncotarget"},{"key":"1060_CR13","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1158\/0008-5472.CAN-13-1657","volume":"73","author":"X Huang","year":"2013","unstructured":"Huang X, Taeb S, Jahangiri S, Emmenegger U, Tran E, Bruce J, et al. miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res. 2013;73:6972\u201386.","journal-title":"Cancer Res"},{"key":"1060_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1667\/RR14185.1","volume":"184","author":"P Gong","year":"2015","unstructured":"Gong P, Zhang T, He D, Hsieh J-T. MicroRNA-145 modulates tumor sensitivity to radiation in prostate Cancer. Radiat Res. 2015;184:630\u20138.","journal-title":"Radiat Res"},{"key":"1060_CR15","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1093\/nar\/gkv273","volume":"43","author":"K Hatano","year":"2015","unstructured":"Hatano K, Kumar B, Zhang Y, Coulter JB, Hedayati M, Mears B, et al. A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation. Nucleic Acids Res. 2015;43:4075\u201386.","journal-title":"Nucleic Acids Res"},{"key":"1060_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2017.02.033","volume":"395","author":"R Bezawy El","year":"2017","unstructured":"El Bezawy R, Cominetti D, Fenderico N, Zuco V, Beretta GL, Dugo M, et al. miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis. Cancer Lett. 2017;395:53\u201362.","journal-title":"Cancer Lett"},{"key":"1060_CR17","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1158\/0008-5472.CAN-08-2894","volume":"69","author":"P Gandellini","year":"2009","unstructured":"Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, et al. MiR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C\u03b5. Cancer Res. 2009;69:2287\u201395.","journal-title":"Cancer Res"},{"key":"1060_CR18","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/bjc.2013.131","volume":"108","author":"Z Hagman","year":"2013","unstructured":"Hagman Z, Haflidad\u00f3ttir BS, Ceder JA, Larne O, Bjartell A, Lilja H, et al. MiR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. Br J Cancer. 2013;108:1668\u201376.","journal-title":"Br J Cancer"},{"key":"1060_CR19","doi-asserted-by":"publisher","first-page":"21414","DOI":"10.3390\/ijms141121414","volume":"14","author":"C Kalogirou","year":"2013","unstructured":"Kalogirou C, Spahn M, Krebs M, Joniau S, Lerut E, Burger M, et al. MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. Int J Mol Sci. 2013;14:21414\u201334.","journal-title":"Int J Mol Sci"},{"key":"1060_CR20","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/cdd.2012.56","volume":"19","author":"P Gandellini","year":"2012","unstructured":"Gandellini P, Profumo V, Casamichele A, Fenderico N, Borrelli S, Petrovich G, et al. MiR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ. 2012;19:1750\u201360.","journal-title":"Cell Death Differ"},{"key":"1060_CR21","first-page":"67","volume":"27","author":"P Gandellini","year":"2014","unstructured":"Gandellini P, Giannoni E, Casamichele A, Taddei ML, Callari M, Piovan C, et al. miR-205 hinders the malignant interplay between prostate Cancer cells and associated fibroblasts. Antioxid Redox Signal. 2014;27:67\u201378.","journal-title":"Antioxid Redox Signal"},{"key":"1060_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.bcp.2013.12.009","volume":"87","author":"M Pennati","year":"2014","unstructured":"Pennati M, Lopergolo A, Profumo V, De Cesare M, Sbarra S, Valdagni R, et al. MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells. Biochem Pharmacol. 2014;87:579\u201397.","journal-title":"Biochem Pharmacol"},{"key":"1060_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.radonc.2007.10.041","volume":"86","author":"G Wanner","year":"2008","unstructured":"Wanner G, Mayer C, Kehlbach R, Rodemann HP, Dittmann K. Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. Radiother Oncol. 2008;86:383\u201390.","journal-title":"Radiother Oncol"},{"key":"1060_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13148-011-0044-4","volume":"2","author":"DV Firsanov","year":"2011","unstructured":"Firsanov DV, Solovjeva LV, Svetlova MP. H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues. Clin Epigenetics. 2011;2:283\u201397.","journal-title":"Clin Epigenetics"},{"key":"1060_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/bjc.1992.371","volume":"66","author":"CY Kim","year":"1992","unstructured":"Kim CY, Giaccia a J, Strulovici B, Brown JM. Differential expression of protein kinase C epsilon protein in lung cancer cell lines by ionising radiation. Br J Cancer. 1992;66:844\u20139.","journal-title":"Br J Cancer"},{"key":"1060_CR26","doi-asserted-by":"crossref","unstructured":"Gandellini P, Rancati T, Valdagni R, Zaffaroni N. miRNAs in tumor radiation response: bystanders or participants? Trends Mol Med. 2014:529\u201339.","DOI":"10.1016\/j.molmed.2014.07.004"},{"key":"1060_CR27","doi-asserted-by":"publisher","first-page":"65457","DOI":"10.18632\/oncotarget.18924","volume":"8","author":"T Koo","year":"2017","unstructured":"Koo T, Cho BJ, Kim DH, Park JM, Choi EJ, Kim HH, et al. MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Oncotarget. 2017;8:65457\u201368.","journal-title":"Oncotarget"},{"key":"1060_CR28","doi-asserted-by":"crossref","unstructured":"Chang JH, Hwang YH, Lee DJ, Kim DH, Park JM, Wu HG, et al. MicroRNA-203 modulates the radiation sensitivity of human malignant glioma cells. Int J Radiat Oncol Biol Phys. 2016.","DOI":"10.1016\/j.ijrobp.2015.10.001"},{"key":"1060_CR29","doi-asserted-by":"publisher","first-page":"11733","DOI":"10.1007\/s13277-015-4773-4","volume":"37","author":"Y Lu","year":"2016","unstructured":"Lu Y, Li T, Wei G, Liu L, Chen Q, Xu L, et al. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204\/ZEB1 axis in nasopharyngeal carcinoma. Tumor Biol. 2016;37:11733\u201341.","journal-title":"Tumor Biol"},{"key":"1060_CR30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","volume":"59","author":"TM Pawlik","year":"2004","unstructured":"Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:928\u201342.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1060_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-17-0244","volume":"16","author":"S Martini","year":"2017","unstructured":"Martini S, Soliman T, Gobbi G, Mirandola P, Carubbi C, Masselli E, et al. PKC\u03b5 controls mitotic progression by regulating centrosome migration and mitotic spindle assembly. Mol Cancer Res. 2017;16:3\u201315.","journal-title":"Mol Cancer Res"},{"key":"1060_CR32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1158\/1541-7786.MCR-12-0482-T","volume":"10","author":"P Javvadi","year":"2012","unstructured":"Javvadi P, Makino H, Das AK, Lin Y-F, Chen DJ, Chen BP, et al. Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance. Mol Cancer Res. 2012;10:1359\u201368.","journal-title":"Mol Cancer Res"},{"key":"1060_CR33","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14728220903338777","volume":"13","author":"H Wu","year":"2009","unstructured":"Wu H, Mo Y-Y. Targeting miR-205 in breast cancer. Expert Opin Ther Targets. 2009;13:1439\u201348.","journal-title":"Expert Opin Ther Targets"},{"key":"1060_CR34","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.18632\/oncotarget.13902","volume":"8","author":"F Pan","year":"2017","unstructured":"Pan F, Mao H, Bu F, Tong X, Li J, Zhang S, et al. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma. Oncotarget. 2017;8:5735\u201352.","journal-title":"Oncotarget"},{"key":"1060_CR35","doi-asserted-by":"publisher","first-page":"8007","DOI":"10.1007\/s13277-015-4656-8","volume":"37","author":"R Hezova","year":"2016","unstructured":"Hezova R, Kovarikova A, Srovnal J, Zemanova M, Harustiak T, Ehrmann J, et al. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus. Tumour Biol. 2016;37:8007\u201318.","journal-title":"Tumour Biol"},{"key":"1060_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.4161\/cc.11.4.19228","volume":"11","author":"C Qu","year":"2012","unstructured":"Qu C, Liang Z, Huang JL, Zhao R, Su C, Wang S, et al. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle. 2012;11:785\u201396.","journal-title":"Cell Cycle"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1060-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1060-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1060-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T07:51:38Z","timestamp":1606377098000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1060-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1060-z","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"21 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Ethics Committee for Animal Experimentation of Fondazione IRCCS Istituto Nazionale dei Tumori and by the Italian Health Ministry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}